BioAtla

BioAtla is a San Diego-based biotechnology company that leverages its proprietary Conditionally Active Biologics™ (CAB) and Comprehensive Integrated Antibody Optimization (Ciao!™) platforms to develop novel monoclonal antibody and cell-based therapeutic technologies. BioAtla develops new treatment methods, improves therapeutic indicators, and has the potential to revolutionize cancer treatment.